Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ImpediMed - Appendix 4C & Quarterly Activities Report (ASX:IPD)

To view the report, download the attached PDF.

ImpediMed - AstraZeneca extends and increases Renal Contract (ASX:IPD)

Key Highlights * AstraZeneca extends its second contract for a Phase IIb trial, which is utilising SOZO® to measure fluid volume in patients with chronic kidney disease, by 3 months. * In ad...read more

ImpediMed - Appendix 4D and Interim Financial Report (ASX:IPD)

To view the appendix, download the attached PDF.

ImpediMed Announces End Stage Renal Disease Trial Agreement (ASX:IPD)

ImpediMed Limited (ASX.IPD) is pleased to announce it has entered into an agreement with balboa RESEARCH SMO+ (“Balboa”) and Frenova Renal Research, a Fresenius Medical Care Company, to ...read more

ImpediMed - PREVENT Trial Peer-Reviewed and Published (ASX:IPD)

ImpediMed Limited (ASX.IPD) is pleased to announce the PREVENT Trial results have been peer-reviewed and published in Lymphatic Research and Biology, a journal dedicated to research on lymphatic bio...read more

ImpediMed - Appendix 4C & Quarterly Activities Report (ASX:IPD)

Robust results -- Robust quarter despite meaningful impact from Omicron variant -- Record results in Q2 FY’22 for SOZO®SaaS revenue -- $50.8m cash balance and fully funded to cashflow...read more

ImpediMed - Share Purchase Plan Successfully Completed (ASX:IPD)

ImpediMed Limited (ImpediMed or the Company) (ASX:IPD) is pleased to announce the successful completion of its Share Purchase Plan (SPP). The SPP closed on Thursday, 12 November 2021 heavily oversub...read more

ImpediMed - Application for quotation of securities (ASX:IPD)

To view the Application for quotation of +securities, download the attached PDF.

ImpediMed - Amendments to Constitution (ASX:IPD)

ImpediMed Limited (ImpediMed) (ASX:IPD) advises that amendments to its Constitution were approved by a special resolution of shareholders at the Company’s Annual General Meeting held on 10 Nov...read more

ImpediMed - Results of Meeting (ASX:IPD)

Set out below are the results of the 2021 Annual General Meeting (AGM) held earlier today. All resolutions put to the AGM were decided by a poll. For more information, download the attached PDF. ...read more

ImpediMed - 2021 Annual General Meeting - Chairman's Address (ASX:IPD)

So welcome and thank you for joining us today. I hope that all of you and your families are healthy and are continuing to successfully navigate this pandemic. As I begin my prepared remarks, I wo...read more

ImpediMed - AGM Presentation - November 2021 (ASX:IPD)

ImpediMed Limited (ImpediMed) (ASX: IPD) provides the attached CEO’s presentation to be delivered at today’s Annual General Meeting commencing at 9.00am AEDT. The webcast of the AGM c...read more

ImpediMed - AstraZeneca extends and increases HF & Renal Contract (ASX:IPD)

Key Highlights AstraZeneca extends its contract for the Phase IIb trial, which is utilising SOZO® to measure fluid volume in patients with heart failure and chronic kidney disease, by 3 mont...read more

ImpediMed - Share Purchase Plan Offer Booklet (ASX:IPD)

You should read this Booklet in full. Eligible Shareholders have the opportunity to participate in the Share Purchase Plan offer by applying for up to $30,000 of new Shares without incurring brokera...read more

ImpediMed's Share Purchase Plan Opens (ASX:IPD)

The Share Purchase Plan (SPP) announced by ImpediMed Limited (ImpediMed or the Company) (ASX: IPD) on Wednesday, 27 October 2021 opens today. Eligible Shareholders in Australia and New Zealand now h...read more

Viewing: 1 - 15 of 29 Previous | Next